Viewing Study NCT06972992


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2025-12-27 @ 10:33 AM
Study NCT ID: NCT06972992
Status: COMPLETED
Last Update Posted: 2025-12-18
First Post: 2025-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
Sponsor: Ascletis Pharma (China) Co., Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module